Harumi Kakuda

1.6k total citations
28 papers, 947 citations indexed

About

Harumi Kakuda is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Oncology. According to data from OpenAlex, Harumi Kakuda has authored 28 papers receiving a total of 947 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hematology, 11 papers in Public Health, Environmental and Occupational Health and 7 papers in Oncology. Recurrent topics in Harumi Kakuda's work include Acute Myeloid Leukemia Research (14 papers), Acute Lymphoblastic Leukemia research (11 papers) and Hematopoietic Stem Cell Transplantation (10 papers). Harumi Kakuda is often cited by papers focused on Acute Myeloid Leukemia Research (14 papers), Acute Lymphoblastic Leukemia research (11 papers) and Hematopoietic Stem Cell Transplantation (10 papers). Harumi Kakuda collaborates with scholars based in Japan, United States and Belgium. Harumi Kakuda's co-authors include Dario Campana, Chihaya Imai, Hiroyuki Fujisaki, Wing Leung, Paul W. Eldridge, Timothy Lockey, Jing Ma, Noriko Shimasaki, Charles G. Mullighan and Takeyuki Sato and has published in prestigious journals such as Blood, Cancer Research and Oncogene.

In The Last Decade

Harumi Kakuda

28 papers receiving 931 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Harumi Kakuda 586 474 398 211 98 28 947
Paul W. Eldridge 750 1.3× 627 1.3× 361 0.9× 235 1.1× 51 0.5× 23 1.1k
Marlies Götz 358 0.6× 276 0.6× 326 0.8× 224 1.1× 51 0.5× 32 682
Susanne Hofmann 284 0.5× 462 1.0× 287 0.7× 303 1.4× 47 0.5× 36 757
K Pouwels 394 0.7× 319 0.7× 258 0.6× 178 0.8× 95 1.0× 13 729
Bartosz Grzywacz 960 1.6× 597 1.3× 266 0.7× 204 1.0× 23 0.2× 31 1.2k
Bijan Moshaver 210 0.4× 225 0.5× 437 1.1× 253 1.2× 89 0.9× 20 743
Sunil S. Raikar 252 0.4× 405 0.9× 108 0.3× 205 1.0× 81 0.8× 37 639
Susan K. Fautsch 1.5k 2.5× 1.0k 2.2× 624 1.6× 130 0.6× 45 0.5× 9 1.7k
Stuart J. Ings 202 0.3× 237 0.5× 452 1.1× 149 0.7× 50 0.5× 24 695
Tamotsu Yamagami 485 0.8× 202 0.4× 170 0.4× 390 1.8× 131 1.3× 17 897

Countries citing papers authored by Harumi Kakuda

Since Specialization
Citations

This map shows the geographic impact of Harumi Kakuda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harumi Kakuda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harumi Kakuda more than expected).

Fields of papers citing papers by Harumi Kakuda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harumi Kakuda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harumi Kakuda. The network helps show where Harumi Kakuda may publish in the future.

Co-authorship network of co-authors of Harumi Kakuda

This figure shows the co-authorship network connecting the top 25 collaborators of Harumi Kakuda. A scholar is included among the top collaborators of Harumi Kakuda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harumi Kakuda. Harumi Kakuda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morimoto, Akira, et al.. (2024). Trametinib for a child with refractory Rosai–Dorfman–Destombes disease harboring a novel somatic mutation in MAP2K1. International Journal of Hematology. 120(4). 520–524. 3 indexed citations
2.
Sakashita, Kazuo, Nao Yoshida, Hideki Muramatsu, et al.. (2023). Allogeneic Hematopoietic Cell Transplantation for Juvenile Myelomonocytic Leukemia with a Busulfan, Fludarabine, and Melphalan Regimen: JPLSG JMML-11. Transplantation and Cellular Therapy. 30(1). 105.e1–105.e10. 1 indexed citations
3.
Honda, Yuko, Hideki Muramatsu, Shinsuke Hirabayashi, et al.. (2021). A retrospective analysis of azacitidine treatment for juvenile myelomonocytic leukemia. International Journal of Hematology. 115(2). 263–268. 5 indexed citations
4.
Moritake, Hiroshi, Shiro Tanaka, Takako Miyamura, et al.. (2020). The outcomes of relapsed acute myeloid leukemia in children: Results from the Japanese Pediatric Leukemia/Lymphoma Study Group AML‐05R study. Pediatric Blood & Cancer. 68(1). e28736–e28736. 12 indexed citations
5.
Miyamura, Takako, Kazuko Kudo, Ken Tabuchi, et al.. (2019). Hematopoietic stem cell transplantation for pediatric acute myeloid leukemia patients with KMT2A rearrangement; A nationwide retrospective analysis in Japan. Leukemia Research. 87. 106263–106263. 6 indexed citations
6.
7.
Mitsui, Tetsuo, Naoto Fujita, Yuhki Koga, et al.. (2019). The effect of graft‐versus‐host disease on outcomes after allogeneic stem cell transplantation for refractory lymphoblastic lymphoma in children and young adults. Pediatric Blood & Cancer. 67(4). e28129–e28129. 4 indexed citations
8.
Takedani, Hideyuki, Akira Ishiguro, Masataka Ishimura, et al.. (2019). Perioperative safety and haematostatic efficacy of a new bypassing agent pd-FVIIa/FX (Byclot) in haemophilia patients with high-responding type inhibitors. Blood Coagulation & Fibrinolysis. 30(8). 385–392. 4 indexed citations
9.
Yoshida, Nao, Hirotoshi Sakaguchi, Miharu Yabe, et al.. (2019). Clinical Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation in Children with Juvenile Myelomonocytic Leukemia: A Report from the Japan Society for Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 26(5). 902–910. 18 indexed citations
10.
Tomizawa, Daisuke, Masanori Yoshida, Tadakazu Kondo, et al.. (2018). Allogeneic hematopoietic stem cell transplantation for children and adolescents with high-risk cytogenetic AML: distinctly poor outcomes of FUS-ERG-positive cases. Bone Marrow Transplantation. 54(3). 393–401. 13 indexed citations
11.
Hishiki, Tomoro, Hiroshi Horie, Katsumi Yotsumoto, et al.. (2014). Histological features of primary tumors after induction or high-dose chemotherapy in high-risk neuroblastoma. Pediatric Surgery International. 30(9). 919–926. 9 indexed citations
12.
Yabe, Miharu, Yoshitoshi Ohtsuka, Kenichiro Watanabe, et al.. (2014). Transplantation for juvenile myelomonocytic leukemia: a retrospective study of 30 children treated with a regimen of busulfan, fludarabine, and melphalan. International Journal of Hematology. 101(2). 184–190. 27 indexed citations
13.
Hishiki, Tomoro, Takeshi Saito, Tetsuya Mitsunaga, et al.. (2013). Optimal surgical treatment and urological outcomes in boys with pelvic and urogenital rhabdomyosarcomas and soft tissue sarcomas. Pediatric Surgery International. 29(10). 1077–1082. 3 indexed citations
14.
Fujisaki, Hiroyuki, Harumi Kakuda, Noriko Shimasaki, et al.. (2009). Expansion of Highly Cytotoxic Human Natural Killer Cells for Cancer Cell Therapy. Cancer Research. 69(9). 4010–4017. 471 indexed citations
15.
Marin, Virna, Harumi Kakuda, Erica Dander, et al.. (2007). Enhancement of the anti-leukemic activity of cytokine induced killer cells with an anti-CD19 chimeric receptor delivering a 4-1BB-ζ activating signal. Experimental Hematology. 35(9). 1388–1397. 45 indexed citations
16.
Sato, Takeyuki, et al.. (2000). HIV Infection of Megakaryocytic Cell Lines. Leukemia & lymphoma. 36(3-4). 397–404. 22 indexed citations
17.
Kakuda, Harumi, Takeyuki Sato, Yasuhide Hayashi, et al.. (1996). A novel human leukaemic cell line, CTS, has a t(6;11) chromosomal translocation and characteristics of pluripotent stem cells. British Journal of Haematology. 95(2). 306–318. 21 indexed citations
18.
Sato, Takeyuki, Setsuo Ota, Harumi Kakuda, et al.. (1995). Expression of Multidrug Resistant Gene (mdr-1/P-glycoprotein) in a Megakaryoblastic Cell Line, CMK, and its Enhancement During Megakaryocytic Differentiation. Leukemia & lymphoma. 18(5-6). 515–520. 4 indexed citations
19.
Ota, Setsuo, Takeyuki Sato, Harumi Kakuda, et al.. (1995). Expression of MDR-1/P-Glycoprotein in Childhood Acute Megakaryoblastic Leukemia Cells. Leukemia & lymphoma. 19(5-6). 431–436. 1 indexed citations
20.
Fuse, Akira, et al.. (1991). Interleukin 6, a possible autocrine growth and differentiation factor for the human megakaryocytic cell line, CMK. British Journal of Haematology. 77(1). 32–36. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paul W. Eldridge Breakdown of academic impact, for papers by Marlies Götz Breakdown of academic impact, for papers by Susanne Hofmann Breakdown of academic impact, for papers by K Pouwels Breakdown of academic impact, for papers by Bartosz Grzywacz Breakdown of academic impact, for papers by Bijan Moshaver Breakdown of academic impact, for papers by Sunil S. Raikar Breakdown of academic impact, for papers by Susan K. Fautsch Breakdown of academic impact, for papers by Stuart J. Ings Breakdown of academic impact, for papers by Tamotsu Yamagami
Rankless by CCL
2026